Progress in the treatment of acute lung injury with Mesenchymal stem cells

Basic & Clinical Medicine ›› 2009, Vol. 29 ›› Issue (9): 1002-1006.

• 短篇综述 • Previous Articles Next Articles

Progress in the treatment of acute lung injury with Mesenchymal stem cells

Li-kun ZHENG, Lei ZHANG, Nai-yao CHEN, Shou-ling WU, Hui ZHAO

North China Coal Medical College Kailuan Hospital Affiliated to North China Coal Medical College

Received:2008-10-27 Revised:2008-12-04 Online:2009-09-20 Published:2009-09-20

Abstract

Abstract: Mesenchymal stem cell is a kind of multipotent hematopoietic stem cell. In the acute lung injury, it can differentiate into TypeⅠand TypeⅡepithelial cell, and repair impaired organization. In addition, mesenchymal stem cells have benefit effects in the treatment of lung injury by reducing proinflammatory factors IL-1,MIP-2,INF-γ, TNF-α, increasing antiinflammatory factors IL-10,IL-1ra, IL-13 and alleviating inflammatory response to the acute lung injury.

Key words: acute lung injury, mesenchymal stem cells, inflammatory response

CLC Number:

R563.9

Li-kun ZHENG; Lei ZHANG; Nai-yao CHEN; Shou-ling WU; Hui ZHAO. Progress in the treatment of acute lung injury with Mesenchymal stem cells[J]. Basic & Clinical Medicine, 2009, 29(9): 1002-1006.

[1]	ZHANG Lulu, TIAN Hui. Parthenolide alleviates sepsis-induced acute lung injury in rat models by regulating the ferroptosis pathway [J]. Basic & Clinical Medicine, 2026, 46(9): 1207-1212.
[2]	LIU Cuiling, YU Shuna. Research progress in the role of NLRP3 inflammasome in hepatic ischemia-reperfusion injury [J]. Basic & Clinical Medicine, 2026, 46(7): 1004-1008.
[3]	ZHANG Yuechuan. Low expression of PDGFRA in bone marrow mesenchymal stem cells from patients with adolescent idiopathic scoliosis and its effects on osteogenic differentiation and proliferation [J]. Basic & Clinical Medicine, 2026, 46(6): 784-790.
[4]	ZHANG Tengyu, WU Ting, WU Xiang. Research progress in retinoic acid in cognitive impairment disorders [J]. Basic & Clinical Medicine, 2026, 46(5): 717-720.
[5]	WU Yi, XIA Likun. Research progress of olfactomedin 4 in regulating immune inflammatory response [J]. Basic & Clinical Medicine, 2026, 46(4): 587-591.
[6]	ZHU Min, TANG Miaomiao. Advances in hydrogen sulfide therapy for acute lung injury [J]. Basic & Clinical Medicine, 2026, 46(4): 592-596.
[7]	YUAN Ce, YE Cuicui, GUO Chang′an, LUO Laisheng, LIU Yuezhen. Role of neutrophil extracellular traps in sepsis-related acute lung injury [J]. Basic & Clinical Medicine, 2026, 46(4): 597-601.
[8]	CUI Yudi, ZHANG Fengchuan, LI Yuanwen, YANG Bilian. Qingshi anti-itch ointment alleviaties imiquimod-induced psoriatic skin lesions in mice [J]. Basic & Clinical Medicine, 2026, 46(2): 164-169.
[9]	CAI Qian, JIANG Tianxiang, PAN Zixin, GAN Lin, MA Congcong, LIN Xianming. Research progress of acupuncture combined with mesenchymal stem cell therapy for stroke [J]. Basic & Clinical Medicine, 2026, 46(10): 1419-1423.
[10]	LI Nan, ZHANG Guitao, WANG Bin, FENG Yao, LI Shujuan, ZHOU Yinghua. Correlation between inflammatory response-related indicators and poor outcomes of in-hospital patients with symptomatic stroke [J]. Basic & Clinical Medicine, 2025, 45(8): 1083-1087.
[11]	YIN Huarun, ZHAO Ning, WU Zhiyuan, LI Yongjun, YIN Hongchao. Dermatopontin promotes abdominal aortic aneurysm progression via the IL-1β-COL1A1 axis [J]. Basic & Clinical Medicine, 2025, 45(7): 918-925.
[12]	CHEN Yunhua, LI Di, ZHAO Xiaoyan, CHEN Ming, LI Hongling, ZHAO Chunhua. Knockdown of human-specific lncRNA MEK6-AS1 improves osteogenic differentiation of senescent mesenchymal stem cells [J]. Basic & Clinical Medicine, 2025, 45(5): 568-574.
[13]	WANG Tingting, QIN Haidong. Mechanisms and therapeutic strategies of sepsis-associated cytokine storm [J]. Basic & Clinical Medicine, 2025, 45(2): 263-267.
[14]	LIU Zhiqiang, GU Xufang, NI Aixin, FAN Shanshan. Clinical research progress on mesenchymal stem cells in the treatment of chronic limb-threatening ischemia [J]. Basic & Clinical Medicine, 2025, 45(11): 1511-1515.
[15]	YANG Ruotong, ZHAO Guoying, WANG Hao. Pathogenesis of acute lung injury of the newborns [J]. Basic & Clinical Medicine, 2025, 45(1): 135-139.

Progress in the treatment of acute lung injury with Mesenchymal stem cells

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments